AI drug discovery firm Exscientia is out to change the pharmaceutical industry
Exscientia has set out its ambition to become the "most creative and productive" drug discovery organisation in the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Oct 19
Exscientia has set out its ambition to become the "most creative and productive" drug discovery organisation in the…
Trinity College scientists claim to have identified a protein linked to lower blood sugar levels that may help…
In a world where supply chains can span multiple national borders, and the regulatory environment is becoming more…
The way clinical trials are conducted in the EU will experience a significant shift when Regulation (EU) no.…
A number of strategies are being developed to help the UK compete in the global research market post-Brexit,…
Choosing between full-service and functional-service outsourcing models isn’t a new debate in the pharmaceutical and biotech industries, but…
Choosing comparators is often an onerous process that involves navigating a lot of different models. A key decision…
The growth of direct-to-patient (DtP) clinical trial strategies is expected to continue for the foreseeable future. Adopting a…
Social media is a powerful tool for patient recruitment, providing a valuable addition to more traditional methods. It…
The variety and quantity of data available for clinical trials is greater than ever before. While this promises…